Top Republicans Give First Year Under Trump 2.0 a Failing Grade

Congress enacted just 38 laws in 2025—the weakest first-year legislative output in decades versus 78 in Trump’s 2017 first year, 68 under Biden and 119 under Obama—while the White House moved policy through a surge of executive orders and the Senate devoted roughly 60% of votes to confirmations. A record 43-day government shutdown in October–November and intra-party strategy failures left key issues like healthcare subsidies and border policy unresolved, heightening policy uncertainty ahead of midterms and complicating the outlook for fiscal and regulatory predictability.

Analysis

Market structure: Legislative paralysis and reliance on executive orders shifts winners toward large, national incumbents (defense: LMT, RTX, GD; large insurers: UNH, CVS) that can transact with agencies outside fast-moving Congressional windows, and toward defensive sectors (XLU, XLP) as fiscal clarity fades. Losers include small-caps and regional-exposed firms (IWM, KRE) and parts of healthcare sensitive to subsidy law (HCA, HUM) where reimbursement or enrollment swings >10–20% can rapidly compress earnings. Cross-asset: expect safe-haven bid into USTs (IEF/TLT) and USD (UUP) around funding deadlines, with short-term volatility spikes in rates and FX; commodities tied to growth (industrial metals) face softer demand.

Risk assessment: Tail risks include an abrupt 2–6 week government funding gap or judicial overturning of major EOs causing 50–150 bps swings in 2s/10s and equity VIX jumping +40–100% intramonth. Immediate (days) risks center on shutdown deadlines and court rulings; short-term (weeks–months) on subsidy expirations and midterm polling; long-term (quarters–years) on codification or reversal of executive policies that alter regulatory regimes. Hidden dependency: nominee confirmations (staffing) create implementation lags that mask policy effects until revealed by agency guidance or enforcement actions.

Trade implications: Tactical hedges: buy duration (IEF/TLT) and USD (UUP) into budget showdowns; use 3-month VIX call spreads to cap hedging cost. Relative-value: rotate away from small-cap/cyclicals (IWM, XLI) into staples/utilities (XLP, XLU) and select defense primes. Healthcare: avoid/short hospital operators with high Medicare/Medicaid mix (HCA) until subsidy path clears; prefer diversified insurers (UNH) if subsidies look likely to be extended.

Contrarian angles: Consensus underestimates speed of reversal risk — many EOs are litigatable and market pricing often ignores a 30–60% chance of partial reversal in 12 months. Historical parallels (2013 shutdown, 2011 debt-ceiling) show short, sharp risk-premium spikes then mean-reversion; trade the volatility, not direction. Unintended consequence: protracted dysfunction can concentrate returns in global large-caps and defensive cash generative businesses — overweight those on 3–12 month horizon.

Key Decisions for Investors

• Establish a 2–4% portfolio long position in 7–10yr Treasuries via IEF as a hedge into the next 60–90 days; if 10y yield falls 25–50 bps within a week, scale to 5% total and trim if yield re-steepens above entry+40 bps.
• Implement a 1–2% long USD hedge via UUP for 30–90 days around federal funding deadlines and court rulings; unwind if DXY drops >3% from current levels or if Congress passes multi-month funding extension.
• Buy a 3-month VIX call spread (e.g., buy near-the-money 3-month call, sell a higher strike to cap cost) sized to cover 2–3% portfolio drawdowns; target payoff if VIX spikes +40% intramonth around a shutdown or major ruling.
• Rotate sector weights: reduce cyclical exposure by 3–5% (sell XLI/IWM) and increase defensives by 3–5% (buy XLP/XLU). Reassess after 90 days or upon passage of any major fiscal/tax legislation.
• Take a tactical 1–2% short position in HCA (or pair: long UNH, short HCA) with tight stop-loss at 10% and a horizon of 60–180 days; close if Congress codifies subsidies within 60 days or if enrollment/margin data outperforms by >5%.